Biventricular (BiV) pacemakers and pacemaker-defibrillator (ICD) systems have been shown to improve cardiac function and diminish frequency of heart failure hospitalizations in patients with severe left ventricular (LV) dysfunction and intraventricular conduction disease. The basis for these beneficial effects is multifactorial (1-15). In the case of BiV pacemakers, the primary benefit is presumed to be improved synchronization of ventricular contraction in the diseased heart; for BiV-ICDs an additional antiarrhythmic benefit is provided by the defibrillation feature.
Given the potential of an incremental survival benefit with BiV-ICDs versus BiV pacing alone, there has been a trend toward utilizing BiV-ICD devices in
主办单位:杭州德灵电子商务有限公司 杭州汉皇网络科技有限公司浙江省护理学会重症监护专业委员会网站协办单位：浙江省人民医院设备科 ;浙ICP备10209442号-3
联系电话:0571－85065806 传真:0571－85065896 地址:杭州下城区高新技术产业基地电子商务园区费家塘路588号4号楼402-403室
Copyrigh ©2001-2009版权所有_杭州德灵电子商务有限公司 杭州汉皇网络科技有限公司 本网站法律顾问:汪卓君律师(浙江杭天信律师事务所)
execute:62.500
